Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, January 28, 2015
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
OGT Launch Cancer Sequencing Panel at ACGS
Wednesday, April 30, 2014
Accurate solid tumour profiling for clinical and translational research

Molecular Devices Introduces Microplate Reader and Washer
Monday, April 28, 2014
The inexpensive and versatile EMax® Plus Microplate Reader and MultiWash™+ Microplate Washer are designed for labs just starting up or looking to extend capabilities with affordable, yet reliable instrumentation that utilizes the industry-standard SoftMax® Pro Microplate Data Acquisition and Analysis Software.

Quotient Clinical Extends its Translational Pharmaceutics™ Platform
Friday, April 25, 2014
Company will employ its manufacturing capabilities to supply specialist oncology centers with drug products.

Exiqon Launches LNA™ microRNA Mimics with No Off-Target Effect
Thursday, April 24, 2014
New miRCURY LNA™ microRNA Mimics allow scientists to investigate the biological function of a specific microRNA.

Fluxion Biosciences Introduces IsoFlux™ NGS Assay Kits
Tuesday, April 22, 2014
New kits enable mutation detection from circulating tumor cells using next-generation sequencing.

Cancer Researcher Wins Cytation™ 3 in BioTek's Contest!
Saturday, April 12, 2014
Dr. Jeff Peterson wins Cytation™ 3 cell imaging multi-mode reader in "Think Possible" Application Contest.

Immunovaccine's DepoVax™ Technology Underpins New Experimental Therapy for Cancers
Wednesday, April 09, 2014
IMV vaccine adjuvant technology of choice for Dana-Farber's HPV-related cancer clinical trial.

Life Technologies Releases New Research Tool
Tuesday, April 08, 2014
Oncomine NGS RNA-Seq Gene Expression Browser extends the Oncomine NGS Power Tools product offering.

Bio-Rad’s Droplet Digital™ PCR Technology Highlighted at the 2014 AACR Annual Meeting
Tuesday, April 08, 2014
Introduced less than three years ago, ddPCR is rapidly gaining acceptance within the cancer research community. In fact, from 2012 to 2013, the number of cancer research papers involving ddPCR has nearly quintupled.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 669
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
SELECTBIO
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn